Badger John, Chie-Leon Barbara, Logan Cheyenne, Sridhar Vandana, Sankaran Banumathi, Zwart Peter H, Nienaber Vicki
Zenobia Therapeutics Inc., 505 Coast Boulevard South, Suite 111, La Jolla, CA 92037, USA.
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2012 Dec 1;68(Pt 12):1477-81. doi: 10.1107/S174430911204571X. Epub 2012 Nov 28.
Acinetobacter baumannii is a Gram-negative pathogenic bacterium which is resistant to most currently available antibiotics and that poses a significant health threat to hospital patients. LpxA is a key enzyme in the biosynthetic pathway of the lipopolysaccharides that are components of the bacterial outer membrane. It is a potential target for antibacterial agents that might be used to fight A. baumannii infections. This paper describes the structure determination of the apo form of LpxA in space groups P2(1)2(1)2(1) and P6(3). These crystal forms contained three and one protein molecules in the asymmetric unit and diffracted to 1.8 and 1.4 Å resolution, respectively. A comparison of the conformations of the independent protein monomers within and between the two crystal asymmetric units revealed very little structural variation across this set of structures. In the P6(3) crystal form the enzymatic site is exposed and is available for the introduction of small molecules of the type used in fragment-based drug discovery and structure-based lead optimization.
鲍曼不动杆菌是一种革兰氏阴性致病细菌,对目前大多数可用抗生素具有抗性,对医院患者构成重大健康威胁。LpxA是脂多糖生物合成途径中的关键酶,脂多糖是细菌外膜的组成成分。它是可能用于对抗鲍曼不动杆菌感染的抗菌剂的潜在靶点。本文描述了在空间群P2(1)2(1)2(1)和P6(3)中LpxA无配体形式的结构测定。这些晶体形式在不对称单元中分别包含三个和一个蛋白质分子,衍射分辨率分别为1.8 Å和1.4 Å。对两个晶体不对称单元内和之间独立蛋白质单体的构象进行比较,发现在这组结构中结构变化很小。在P6(3)晶体形式中,酶活性位点暴露,可用于引入基于片段的药物发现和基于结构的先导化合物优化中使用的小分子类型。